TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24419418

Group type: EXPERIMENTAL
Intervention: Maintenance pemetrexed (500 mg/m)
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 22525900

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate alone
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Metformin alone
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate plus metformin
Number of subjects: 626

Group type: COMPARATOR
Intervention: Anovulatory cycles with progestin withdrawal
Number of subjects: 626

Group type: COMPARATOR
Intervention: Anovulatory cycles without progestin withdrawal
Number of subjects: 626

Group type: COMPARATOR
Intervention: Spontaneous menses
Number of subjects: 626
Study: 19204305

Group type: EXPERIMENTAL
Intervention: CRT‐P
Number of subjects: 1520

Group type: EXPERIMENTAL
Intervention: CRT‐D
Number of subjects: 1520

Group type: COMPARATOR
Intervention: Optimal pharmacological therapy
Number of subjects: 1520
Study: 17333304

Group type: EXPERIMENTAL
Intervention: Visalys whitening (VW)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Opalescence PF (OP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (VW and OP)
Number of subjects: 60
Study: 15304029

Group type: COMPARATOR
Intervention: Combination chemotherapy (CT) alone
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (CT) plus low-molecular-weight heparin (LMWH)
Number of subjects: 84
Study: 11236499

Group type: EXPERIMENTAL
Intervention: Immunotherapy (oral hyposensitization with mite allergens) in combination with ointment containing retinopalmitate and methyluracil
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard treatment combined with the administration of placebo
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 99
Study: 10082447

Group type: EXPERIMENTAL
Intervention: Sandimmun (SAN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Neoral (NEO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Trough levels
Number of subjects: 10
Study: 8042821

Group type: EXPERIMENTAL
Intervention: Chlorambucil (0.15 mg/kg body weight per day orally) and prednisone (three intravenous pulses of 1 g of methylprednisolone followed by oral prednisone at 0.5 mg/kg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (750 mg/m2 body surface area once every month for 6 months) and methylprednisolone (three intravenous 1-g pulses)
Number of subjects: 18
Study: 2892771

Group type: EXPERIMENTAL
Intervention: Propranolol (doses reducing resting heart rate by 25%)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo (oral vitamin K)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 174
Study: 30374832

Group type: EXPERIMENTAL
Intervention: Xenogenic graft plus modified perforated membranes (MPM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Xenogenic graft plus standard collagen membranes (CM)
Number of subjects: 15
Study: 28694338

Group type: EXPERIMENTAL
Intervention: Commercial web‐based cognitive training program
Number of subjects: 128

Group type: COMPARATOR
Intervention: Web‐based video games (control)
Number of subjects: 128
Study: 25482957

Group type: EXPERIMENTAL
Intervention: WBV (whole-body vibration) plus balance exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: STE (standard balance exercise)
Number of subjects: 20
Study: 23337369

Group type: EXPERIMENTAL
Intervention: Pictograph‐guided adherence counseling
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Standard adherence counseling
Number of subjects: 446

Group type: COMPARATOR
Intervention: General health improvement counseling
Number of subjects: 446
Study: 21342008

Group type: EXPERIMENTAL
Intervention: Bioabsorbable collagen barrier
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-resorbable expanded polytetrafluoroethylene (ePTFE) barrier
Number of subjects: 11
Study: 19774436

Group type: EXPERIMENTAL
Intervention: 8.8 g/day of plant stanols
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no plant stanol esters)
Number of subjects: 49
Study: 17174637

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 9467

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 9467
Study: 15955130

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 3140

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 3140

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg
Number of subjects: 3140

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 3140

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 3140
Study: 11991783

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (76.0 +/- 6.0% of VO2peak)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (44.5 +/- 5.5% of VO2peak)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (62.3 +/- 3.8% of VO2peak)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resting control session
Number of subjects: 10
Study: 10803268

Group type: EXPERIMENTAL
Intervention: Nucleic acid hybridization for HPV DNA detection (group C)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Nucleic acid hybridization for HPV DNA detection (group A and B)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Nucleic acid hybridization with pap smear results
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 236
Study: 7786910

Group type: EXPERIMENTAL
Intervention: Short-term migrants
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Long-term migrants
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Overall psychiatric morbidity
Number of subjects: 198
Study: 2337559

Group type: EXPERIMENTAL
Intervention: Combined lidocaine nerve block with halothane general anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Halothane general anaesthesia alone
Number of subjects: 50
Study: 6932209

Group type: EXPERIMENTAL
Intervention: 50 mg intravaginal PG F2 alpha
Number of subjects: 83

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 83
Study: 31821059

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 118

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 118
Study: 31021884

Group type: EXPERIMENTAL
Intervention: Scenario plus video
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Scenario
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Self-assessment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Follow-up stage at 4-week later
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 27919609

Group type: EXPERIMENTAL
Intervention: Footplate Neuromuscular Electrical Stimulation Device (REVITIVE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 22
Study: 25676084

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP) therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham-EECP
Number of subjects: 17
Study: 23591401

Group type: EXPERIMENTAL
Intervention: Sorafenib 400mg BID
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 21675554

Group type: EXPERIMENTAL
Intervention: Correct information group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Misleading information group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no additional information)
Number of subjects: 43
Study: 19432985

Group type: EXPERIMENTAL
Intervention: LPS treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: rhAPC treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline treatment
Number of subjects: 10
Study: 16704587

Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide anaesthesia
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no anaesthesia)
Number of subjects: 48
Study: 14695390

Group type: EXPERIMENTAL
Intervention: Fixed duration of contrast material injection for 25 seconds (group A)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Fixed duration of contrast material injection for 35 seconds (group B)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Fixed injection rate of 4.0 mL/sec (group C)
Number of subjects: 199
Study: 11720401

Group type: EXPERIMENTAL
Intervention: Typically prepared pureed peach
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pureed peach with a thickening agent added
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pureed peach with a thickening agent added and molded to look like peach slices
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Molded peach
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall liking, liking of taste, texture, and appearance
Number of subjects: 30
Study: 9405908

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8433117

Group type: EXPERIMENTAL
Intervention: Nine different presentations of breast cancer health descriptions
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Descriptions written in the third person with different wording regarding 'cancer'
Number of subjects: 180
Study: 2889416

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg orally every 8 hours
Number of subjects: 45
Study: 29449127

Group type: EXPERIMENTAL
Intervention: Clopidogrel alone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Clopidogrel with PPIs (pantoprazole, omeprazole, rabeprazole, esomeprazole, lansoprazole, dexlansoprazole)
Number of subjects: 28
Study: 26683394

Group type: EXPERIMENTAL
Intervention: Enhanced Zone III REBOA technique with ultrasonography guidance (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard measuring length of catheter insertion technique (Group B)
Number of subjects: 20
Study: 24094879

Group type: COMPARATOR
Intervention: NCPAP range of 4‐6 cmH2O (low NCPAP)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: NCPAP range of 7‐9 cmH2O (high NCPAP)
Number of subjects: 93
Study: 22882399

Group type: EXPERIMENTAL
Intervention: Guaranteed methadone treatment admission upon release
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Methadone in prison and guaranteed continuation of methadone upon release
Number of subjects: 211

Group type: COMPARATOR
Intervention: Passive referral to substance abuse treatment upon release
Number of subjects: 211

Group type: COMPARATOR
Intervention: Counseling in prison without methadone
Number of subjects: 211
Study: 20173643

Group type: EXPERIMENTAL
Intervention: Metamizol 1 g
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lornoxicam 8 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isotonic saline 0.9% (placebo)
Number of subjects: 80
Study: 18728103

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (75, 100, 150, or 200 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous fentanyl (75, 100, 150, or 200 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl
Number of subjects: 0
Study: 15192463

Group type: EXPERIMENTAL
Intervention: Tc‐99m‐labeled anti‐D IgG opsonized autologous RBC scintigraphy (RIS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Tc‐99m heat‐denatured RBC spleen scintigraphy (HDRS)
Number of subjects: 45
Study: 11124351

Group type: EXPERIMENTAL
Intervention: Framing of the question and structure of the problem to activate intuitive principles based on subset relations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard framing of probability and frequency problems
Number of subjects: 0
Study: 9603591

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 12078

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 12078

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12078

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg
Number of subjects: 12078

Group type: EXPERIMENTAL
Intervention: Ondansetron 1 mg
Number of subjects: 12078
Study: 7857040

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (no prophylactic antibiotics)
Number of subjects: 106
Study: 2527940

Group type: EXPERIMENTAL
Intervention: Hevac‐B‐Pasteur
Number of subjects: 72

Group type: COMPARATOR
Intervention: H‐B‐Vax I
Number of subjects: 72

Group type: COMPARATOR
Intervention: Engerix B
Number of subjects: 72
Study: 738078

Group type: EXPERIMENTAL
Intervention: Combined preparation of 40 mg frusemide and 600 mg slow-release potassium chloride
Number of subjects: 10

Group type: COMPARATOR
Intervention: Separate tablets of 40 mg frusemide and 600 mg potassium chloride
Number of subjects: 10
Study: 31456474

Group type: EXPERIMENTAL
Intervention: Active Recovery (AR)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Static Stretching (SS)
Number of subjects: 15
Study: 30753213

Group type: EXPERIMENTAL
Intervention: Activate intervention
Number of subjects: 67
Study: 29137091

Group type: EXPERIMENTAL
Intervention: Ringer lactate solution (RL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Succinylated gelatin injection (Gel)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hypertonic saline hydroxyethyl starch 40 injection (HS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ringer lactate solution (RL) and Succinylated gelatin injection (Gel)
Number of subjects: 36
Study: 25620547

Group type: EXPERIMENTAL
Intervention: Tangerine tomato juice (10 mg lycopene, 94% cis)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Red tomato juice (10 mg lycopene, 10% cis)
Number of subjects: 11
Study: 23512550

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 21896765

Group type: EXPERIMENTAL
Intervention: Auditory language exposure
Number of subjects: 1
Study: 20306936

Group type: EXPERIMENTAL
Intervention: Forgiveness education intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 16958569

Group type: EXPERIMENTAL
Intervention: OROS MPH once daily (n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: IR MPH three times daily (n = 32)
Number of subjects: 64
Study: 15151265

Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ramipril 1.25 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Captopril (after washout period)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ramipril (after washout period)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Captopril (during dialysis)
Number of subjects: 24
Study: 11472790

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) + fluoxetine
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quantitative REMs
Number of subjects: 130
Study: 9144122

Group type: EXPERIMENTAL
Intervention: L. reuteri
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7698722

Group type: EXPERIMENTAL
Intervention: Delta-sleep-inducing peptide (DSIP) 25 nmol/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (0.51 M NaCl)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Orthostatic test (standing upright for 20 min)
Number of subjects: 8
Study: 2951260

Group type: EXPERIMENTAL
Intervention: Fenflumizole 10 mg b.i.d. for four days followed by 10 mg daily for six days (Group I)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fenflumizole 20 mg b.i.d. for four days followed by 20 mg daily for six days (Group II)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study: 31839325

Group type: EXPERIMENTAL
Intervention: Stroke impact domain-mood
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Stroke impact domain-fatigue
Number of subjects: 100
Study: 28750937

Group type: EXPERIMENTAL
Intervention: 60ml of castor oil
Number of subjects: 81

Group type: COMPARATOR
Intervention: 60ml of sunflower oil (control)
Number of subjects: 81
Study: 27397664

Group type: EXPERIMENTAL
Intervention: Suvorexant 20/15 mg
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1260
Study: 24477032

Group type: EXPERIMENTAL
Intervention: 0PEEP
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 5PEEP
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 10PEEP
Number of subjects: 75

Group type: COMPARATOR
Intervention: 5PEEP and 10PEEP
Number of subjects: 75
Study: 23636236

Group type: EXPERIMENTAL
Intervention: Zinc (20 mg elemental zinc/d)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 20632667

Group type: EXPERIMENTAL
Intervention: Ephedrine 5 mg (group A; n = 31)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Phenylephrine 100 ug (group B; n = 31)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 62
Study: 18373147

Group type: EXPERIMENTAL
Intervention: Online screening survey via patient internet portal
Number of subjects: 4017
Study: 16801301

Group type: EXPERIMENTAL
Intervention: Nicotine gum intervention with tailored, brief feedback to promote positive attitudes and accurate knowledge about NRT.
Number of subjects: 97
Study: 12922081

Group type: EXPERIMENTAL
Intervention: Low initial IgG antibody concentrations against pertussis toxin
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: No previous history of pertussis vaccination or disease
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Less than 14 days of cough
Number of subjects: 627
Study: 10804023

Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (2.25 mEq/liter or 2.5 mEq/liter)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular calcium dialysate (3.0 mEq/liter or 3.5 mEq/liter)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined study values at 0, 6, and 12 months
Number of subjects: 33
Study: 8642163

Group type: EXPERIMENTAL
Intervention: 10 mcg HBs vaccine (Recombivax, Merck, Sharp and Dohme)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 12 mcg PreS2 + S vaccine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 24 mcg PreS2 + S vaccine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fourth vaccination (for poor and non-responders)
Number of subjects: 29
Study: 1737453

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition plus human albumin 25 g/L as a continuous infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Parenteral nutrition (control)
Number of subjects: 30
Study: 3896964

Group type: EXPERIMENTAL
Intervention: +cyanidanol-3 (3 g daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29302609

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyles Programme (HeLP) intervention delivered over 1 year, including physical activity workshops, education sessions, drama sessions, and parental support.
Number of subjects: 1324

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1324
Study: 27371884

Group type: EXPERIMENTAL
Intervention: Epi-Care (group 1A, n = 14)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Audio baby monitor (group 1B, n = 13)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Monitoring group (group 1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (group 2, n = 16)
Number of subjects: 43
Study: 23891422

Group type: EXPERIMENTAL
Intervention: Los Angeles Unified School District's food-and-beverage standards of 2004
Number of subjects: 0
Study: 22399076

Group type: EXPERIMENTAL
Intervention: BMS group therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: EDU session
Number of subjects: 48
Study: 20878013

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell (BMMC) transplantation
Number of subjects: 24
Study: 18448233

Group type: EXPERIMENTAL
Intervention: Group A (physiotherapist-guided pelvic floor muscle training)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Group B (pelvic floor muscle training without physiotherapist guidance)
Number of subjects: 85
Study: 18578276

Group type: EXPERIMENTAL
Intervention: Comprehensive educational guidelines
Number of subjects: 72
Study: 15060238

Group type: EXPERIMENTAL
Intervention: Kangaroo care (KC) shortly after delivery for 1 hour
Number of subjects: 47

Group type: COMPARATOR
Intervention: No-treatment standard care (control group)
Number of subjects: 47
Study: 11751716

Group type: COMPARATOR
Intervention: Hypertensive individuals
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Blacks
Number of subjects: 228
Study: 9538712

Group type: EXPERIMENTAL
Intervention: Statistical significance in nursing research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative research and informal knowledge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-quality research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical relevance
Number of subjects: 0
Study: 7685684

Group type: EXPERIMENTAL
Intervention: Diclofenac 50mg/misoprostol 200 micrograms
Number of subjects: 372

Group type: COMPARATOR
Intervention: Diclofenac 50mg
Number of subjects: 372
Study: 3545461

Group type: EXPERIMENTAL
Intervention: L-Dopa plus benserazide
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31808298

Group type: EXPERIMENTAL
Intervention: Low-dose SAR425899 (0.03, 0.06 and 0.09 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-dose SAR425899 (0.06, 0.12 and 0.18 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-dose SAR425899
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-dose SAR425899
Number of subjects: 36
Study: 30183438

Group type: EXPERIMENTAL
Intervention: New adalimumab formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing adalimumab formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 0
Study: 28922422

Group type: EXPERIMENTAL
Intervention: Intensified follow-up protocol
Number of subjects: 0